Jayamani
Jayaraj Jayamani, Seoul KR
Patent application number | Description | Published |
---|---|---|
20100147422 | AMORPHOUS ALLOY AND MANUFACTURING METHOD THEREOF - The present invention relates to an amorphous alloy and a method for manufacturing thereof. The amorphous alloy according to the present invention includes has a chemical formula of Feioo-a-b-c-d-e-f-gCraMobCcBaYeMflg. Here, the M is at least one selected from a group consisting of Al, Co, N1 and Ni, and the I is at least one selected from a group consisting of Mn, P, S, and O as impurities. The a, b, c, d, e, f, and g are satisfied with the compositions of 16.0 wt %≦a<22.0 wt %, 15.0 wt % | 06-17-2010 |
20120024431 | AMORPHOUS ALLOY - The present invention relates to an amorphous alloy and a method for manufacturing thereof. The amorphous alloy according to the present invention includes has a chemical formula of Ni | 02-02-2012 |
Jayaraj Jayamani, Tamilnadu IN
Patent application number | Description | Published |
---|---|---|
20120305142 | METAL ALLOY AND USE THEREOF - A metallic alloy comprising Ti, Zr, Nb, containing an amorphous phase and a quasicrystalline phase and is represented by the formula: | 12-06-2012 |
Munusamy Jayamani, Chennai IN
Patent application number | Description | Published |
---|---|---|
20090247553 | Highly Pure Paliperidone or a Pharmaceutically Acceptable Salt Thereof Substantially Free of Keto Impurity - Provided herein is a highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of keto impurity, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-7,8-dihydro-6H-pyrido[1,2-a]pyrimidin-4,9-dione, a process for the preparation thereof, and pharmaceutical compositions comprising highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of keto impurity. | 10-01-2009 |
20100004447 | PROCESS FOR PREPARATION OF 9-HYDROXY-3-(2-CHLOROETHYL)-2-METHYL-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE HYDROCHLORIDE - Described herein is an improved, commercially viable and industrially advantageous process for the preparation of paliperidone intermediate 9-hydroxy-3-(2-chloroethyl)-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one and its hydrochloride salt. The process provides the paliperidone intermediate in higher yield and reduced reaction time compared to the previously disclosed processes, thereby providing for production of paliperidone and its pharmaceutically acceptable acid addition salts in high purity and in high yield. | 01-07-2010 |